- Home
- EBMT vs IVVD Comparison
EBMT vs IVVD Comparison
Compare EBMT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- IVVD
- Stock Information
- Founded
- EBMT 1922
- IVVD 2020
- Country
- EBMT United States
- IVVD United States
- Employees
- EBMT N/A
- IVVD N/A
- Industry
- EBMT Major Banks
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- IVVD Health Care
- Exchange
- EBMT Nasdaq
- IVVD Nasdaq
- Market Cap
- EBMT 133.9M
- IVVD 123.8M
- IPO Year
- EBMT N/A
- IVVD 2021
- Fundamental
- Price
- EBMT $16.77
- IVVD $0.54
- Analyst Decision
- EBMT
- IVVD Strong Buy
- Analyst Count
- EBMT 0
- IVVD 4
- Target Price
- EBMT N/A
- IVVD $7.89
- AVG Volume (30 Days)
- EBMT 29.8K
- IVVD 2.1M
- Earning Date
- EBMT 04-22-2025
- IVVD 03-20-2025
- Dividend Yield
- EBMT 3.40%
- IVVD N/A
- EPS Growth
- EBMT N/A
- IVVD N/A
- EPS
- EBMT 1.24
- IVVD N/A
- Revenue
- EBMT $80,696,000.00
- IVVD $25,384,000.00
- Revenue This Year
- EBMT N/A
- IVVD $606.63
- Revenue Next Year
- EBMT $6.33
- IVVD $120.93
- P/E Ratio
- EBMT $13.52
- IVVD N/A
- Revenue Growth
- EBMT N/A
- IVVD N/A
- 52 Week Low
- EBMT $12.32
- IVVD $0.36
- 52 Week High
- EBMT $18.37
- IVVD $4.24
- Technical
- Relative Strength Index (RSI)
- EBMT 45.65
- IVVD 33.07
- Support Level
- EBMT $16.07
- IVVD $0.58
- Resistance Level
- EBMT $17.10
- IVVD $0.68
- Average True Range (ATR)
- EBMT 0.25
- IVVD 0.09
- MACD
- EBMT -0.07
- IVVD -0.02
- Stochastic Oscillator
- EBMT 63.64
- IVVD 0.00
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.